BETTER outcomes for children and adults with bronchiectasis
Bronchiectasis is a chronic respiratory disease which currently has no licensed medication specific to the condition. The BronchiEctasis Trial Testing ERdosteine investigates a bronchiectasis-specific pharmaceutical treatment aiming to improve patient outcomes.